CD4 and neoplasm: PD-L1+ Bregs were found to inhibit proliferation of CD8+ T cells, CD4+ CD25- T cells and CD49b+ NK cells in a murine model, via reduced IFN-γ and TNF-α secretion, which ultimately promoted tumour growth in murine breast cancer models [87].